These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8359563)

  • 1. Proceedings Sandostatin, State of the Art. International symposium. Monte Carlo, 1991.
    Digestion; 1993; 54 Suppl 1():1-133. PubMed ID: 8359563
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings, Sandostatin, State of the Art. Monte Carlo, October 9-12, 1991.
    Metabolism; 1992 Sep; 41(9 Suppl 2):1-128. PubMed ID: 1518428
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical use of somatostatin analogues (Sandostatin, SMS 20l-995). Proceedings of a symposium. Amsterdam, November 14, 1986.
    Acta Endocrinol Suppl (Copenh); 1987; 286():1-66. PubMed ID: 2892333
    [No Abstract]   [Full Text] [Related]  

  • 4. Limited predictive value of an acute test with subcutaneous octreotide for long-term IGF-I normalization with Sandostatin LAR in acromegaly.
    de Herder WW; Taal HR; Uitterlinden P; Feelders RA; Janssen JA; van der Lely AJ
    Eur J Endocrinol; 2005 Jul; 153(1):67-71. PubMed ID: 15994747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sandostatin LAR in acromegalic patients: a dose-range study.
    Fløgstad AK; Halse J; Haldorsen T; Lancranjan I; Marbach P; Bruns C; Jervell J
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3601-7. PubMed ID: 8530606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiconformational NMR analysis of sandostatin (octreotide): equilibrium between beta-sheet and partially helical structures.
    Melacini G; Zhu Q; Goodman M
    Biochemistry; 1997 Feb; 36(6):1233-41. PubMed ID: 9063871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with Sandostatin (octreotide).
    Zalatnai A; Szegedi Z; Bocsi J
    Anticancer Res; 2000; 20(3A):1663-6. PubMed ID: 10928088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antiangiogenic effect of sandostatin (octreotide) on the proliferation of the placental vessels.
    Zalatnai A; Timár F
    Anticancer Res; 2002; 22(6C):4225-7. PubMed ID: 12553061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
    Penning C; Vecht J; Masclee AA
    Aliment Pharmacol Ther; 2005 Nov; 22(10):963-9. PubMed ID: 16268971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sandostatin (octreotide)--drug and neurotransmitter (experimental study)].
    Gur'ianov VA; Aliautdin RN; Petrov VE; Kuĭian SM
    Anesteziol Reanimatol; 2002; (5):68-70. PubMed ID: 12611305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.
    Dimitroulopoulos D; Xinopoulos D; Tsamakidis K; Zisimopoulos A; Andriotis E; Markidou S; Panagiotakos D; Chrysohoou C; Bazinis A; Paraskevas E
    Hepatogastroenterology; 2002; 49(47):1245-50. PubMed ID: 12239914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients.
    Ozkan E; Tokmak E; Kucuk NO
    Ann Nucl Med; 2011 Jul; 25(6):425-31. PubMed ID: 21476058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A symposium: Proceedings of the Second International Heart Failure Workshop. May 10-11, 1989, Monte-Carlo, Monaco.
    Am J Cardiol; 1991 May; 67(12):1C-54C. PubMed ID: 1673584
    [No Abstract]   [Full Text] [Related]  

  • 14. Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly.
    Stewart PM; Kane KF; Stewart SE; Lancranjan I; Sheppard MC
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3267-72. PubMed ID: 7593436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long acting sandostatine (sandostatine LAR) in the treatment of acromegaly].
    Priou A; Levesque G; Simonetta C; Lancranjan I; Roger P; Jaquet P
    Ann Endocrinol (Paris); 1995; 56(3):213-8. PubMed ID: 7677407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin sensitivity test using a somatostatin analogue, octreotide (Sandostatin).
    Mimura A; Kageyama S; Maruyama M; Ikeda Y; Isogai Y
    Horm Metab Res; 1994 Apr; 26(4):184-7. PubMed ID: 8082872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings of the discussion: 'Tolerability and safety of Sandostatin'.
    Popovic V; Chayvialle JA; Wass JA
    Digestion; 1993; 54 Suppl 1():104-6. PubMed ID: 8359564
    [No Abstract]   [Full Text] [Related]  

  • 18. The Wellcome International Antiviral Symposium. December 2 to 4, 1987, Monte Carlo, Monaco. Proceedings.
    Am J Med; 1988 Aug; 85(2A):1-213. PubMed ID: 3407672
    [No Abstract]   [Full Text] [Related]  

  • 19. International Symposium on Anaerobic Bacteria and Bacterial Infections. Monte Carlo, Monaco, 25-28 September 1988. Proceedings.
    Rev Infect Dis; 1990; 12 Suppl 2():S121-261. PubMed ID: 2305179
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings of the International Symposium on Omeprazole. Monte-Carlo, Monaco, 11-12 November 1988.
    Scand J Gastroenterol Suppl; 1989; 166():1-184. PubMed ID: 2602910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.